Member news

David Apelian MD PhD MBA, an experienced CEO with significant development and regulatory experience in virology and immune-oncology joins Theolytics

Patients, the NHS and the Life Sciences sector set to benefit from new clinical trials framework being laid in parliament today.

Stablepharma and AJ Vaccines have established the primary commercial distribution deal with proposed terms, in relation to the distribution and commercialisation of the SPVX02 (Td) in Europe, a fridge-free adult booster vaccine for the prevention of Tetanus & Diphtheria.

Momentum Pharma breaks ground by becoming the first organization to receive new certification assessing highest industry standards.

Relation Therapeutics announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis

Inaphaea BioLabs, the translational contract research organisation based at MediCity Nottingham, has announced the promotion of Melissa Barr to Head of Scientific Operations.

Cancer Research Horizons, the innovation arm of Cancer Research UK, is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme.

Poolbeg Pharma announces key insights from its poster presentation at the 66th American Society of Hematology ('ASH') Annual Meeting and Exposition, San Diego, California.

Stablepharma Named Life Sciences Innovation Awards Winner by Leading US News Platform, Fierce Pharma, in the “Biotech Innovation” Category

OMass Therapeutics Strengthens its Leadership Team with the Promotions of Hsin Loke to Chief Operating officer and Jon Roffey to Senior Vice President, Discovery and Non-Clinical

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay.

Today, deepmirror has raised $2.4 million to simplify the adoption of AI for molecule design and enable every company to get drugs to patients faster with their accessible AI-powered platform.

Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.

UCL’s Policy Impact Unit, who work closely with researchers in VaxHub Sustainable, VaxHub Global and the FTHM Hub, have recently published a position paper.

Coulter Partners successfully completed a search assignment for Curve Therapeutics (“Curve”) and is pleased to announce the placement of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer.

The potential presented by Engineering Biology (EngBio), both globally and for the UK, is difficult to overstate. Realisation of this potential across sectors as diverse as health, energy, materials, chemicals production and waste management, will be achieved by providing the right tools to help companies of all sizes as they innovate and translate those innovations to commercial scale.

Brainomix, a pioneer in artificial intelligence (AI) imaging solutions, has been awarded the LSX European Lifestars Award for “Healthtech Company of the Year” by HSBC Innovation Banking, and the “Most Transformative Healthtech Company of the Year” by OBN.

Therakind announces that the United States Patent and Trademark Office has granted a patent protecting the Company’s novel multi-dose, needle-free version of its dry powder nasal drug delivery system, DriDose®.

Stablepharma are delighted to announce that they have been selected to be part of Innovate UK’s prestigious Scaleup Programme, recognising the company's potential to grow exponentially and scale globally.

A new total-body PET scanner that is quicker for the patient and produces higher quality images for faster and earlier diagnosis and treatment of illnesses like cancer and heart conditions, was unveiled by Ministers in London yesterday (Wednesday 27 November).